Official UK procurement notice
Generic Anti Infective Drugs
Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionGeneric Anti Infective Drugs
- Recurrence: The contract will run for 2 years with the possibility to extend for a further 24 months
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Generic Drugs - Tablets & CapsulesAwardedRenewal
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Price: 30
- VFM: 20
- Price Stability: 6
- Minimum Order: 4
Published award criteria (5)
- Quality: Pass/Fail
- Price: 30
- VFM: 20
- Price Stability: 6
- Minimum Order: 4
- Suitability
Any supplier may be disqualified who does not respond to the following in the requisite manner:
- ENTERING GENERAL QUALIFICATION SUPPLIER INFORMATION
NHS Wales Shared Services Partnership Procurement Services utilizes the NHS Supplier Information Database (Sid4Gov) and/or Sell2Wales to manage and assess general prequalification information in the form of a profile. Candidates are requested to either: i) Provide their profile in Sid4Gov as follows: Candidates should register on Sid4Gov at sid4gov.cabinetoffice.gov.uk/organisation/register ↗ and submit their Sid4Gov company profile for publication to the system. Candidates already registered on NHS Sid4Gov must ensure that information is up to date and provide their profile number when responding to this alert. Where access to Sid4Gov is unavailable, please contact the Sid4Gov helpdesk at [email protected] or ii) Register company information on the Sell2Wales website at ww.sell2wales.co.uk.
- SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION
i) Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗ ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title xxxx) and view details e) click…
- Economic & financial standing
As per requirements to complete Sid4Gov profile or registration with Sell2Wales - see III.1.1 for more information on how to complete information
- Technical & professional ability
As per requirements to complete Sid4Gov profile or registration with Sell2Wales - see III.1.1 for more information on how to complete information
- Price carries 60 of 60 points: a 10% discount moves about 6 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Yes · The contract will run for 2 years with the possibility to extend for a further 24 months
- First published
- 16 Jul 2021, 22:45 BST
- Last source update
- 16 Mar 2022, 22:45 GMT
- Award evaluation window
- 16 Aug 2021 – …
- Authority reference
PAD-OJEU-47802- FTS notice number
2022/S 000-007264- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02c945Find a Tender
Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 2 years with an option to extend for up to 24months
How it was run
Official notice- Submission deadline
- 16 Aug 2021, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Participation fee
- document
- Bids opened
- 16 Aug 2021, 12:01 BST
Timeline
16 Aug 2021 → 16 Mar 2022 · 4 dates- Submission deadline16 Aug 2021, 12:00 BST
- Bids opened16 Aug 2021, 12:01 BST
- Contract starts1 Feb 2022
- Notice published16 Mar 2022, 22:45 GMT
Notice history
2 events · 2 releases on Find a Tender · since 16 Mar 2022- Status changed to complete16 Mar 2022, 22:45 GMT
- Buyer details updated16 Mar 2022, 22:45 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD | £188,512 † | — | Awarded |
| Intrapharm Labs | £1,442,868 † | — | Awarded |
| Kent Pharmaceuticals Ltd | £1,646,152 † | — | Awarded |
| Martindale | £291,828 † | — | Awarded |
| Merck Sharp & Dohme UK Ltd | £1,107,476 † | — | Awarded |
| Mercury Pharmaceuticals Limited | £870,616 † | — | Awarded |
| Morningside Pharmaceuticals Limited | £79,632 † | — | Awarded |
| Neon Healthcare | £158,788 † | — | Awarded |
| Pfizer Ltd | £226,644 † | — | Awarded |
| Ranbaxy | £1,519,336 † | — | Awarded |
16 further award records carry no date or value.
Contracts
Generic Anti-Infective Drugs · ACCORD-UK LTD
- Signed
- 31 Jan 2022
- Value
- £188,512
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Intrapharm Labs
- Signed
- 31 Jan 2022
- Value
- £1,442,868
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Kent Pharmaceuticals Ltd
- Signed
- 31 Jan 2022
- Value
- £1,646,152
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Martindale
- Signed
- 31 Jan 2022
- Value
- £291,828
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Merck Sharp & Dohme UK Ltd
- Signed
- 31 Jan 2022
- Value
- £1,107,476
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Mercury Pharmaceuticals Limited
- Signed
- 31 Jan 2022
- Value
- £870,616
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Morningside Pharmaceuticals Limited
- Signed
- 31 Jan 2022
- Value
- £79,632
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Neon Healthcare
- Signed
- 31 Jan 2022
- Value
- £158,788
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Pfizer Ltd
- Signed
- 31 Jan 2022
- Value
- £226,644
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs · Ranbaxy
- Signed
- 31 Jan 2022
- Value
- £1,519,336
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £21,212
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £63,568
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £155,524
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £35,068
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £98,168
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £311,828
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £1,162,940
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £212,672
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £181,676
- Period
- … – 31 Jan 2024
- Status
- active
Generic Anti-Infective Drugs
- Signed
- 31 Jan 2022
- Value
- £302,868
- Period
- … – 31 Jan 2024
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 33bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- eTenderwalesContracting authorityCentral purchasing bodyBody governed by public lawHealth
Dispute resolution & review bodies
- NWSSP NHS Wales Shared Services Partnership - Procurement Services (as hosted by Velindre NHS Trust)Review body
Bidders & participating suppliers
26 commercial parties on the notice- Accord-UKAwarded supplier
- Baxter HealthcareAwarded supplier
- Bowmed IbisqusAwarded supplier
- Crescent PharmaAwarded supplier
- Flynn PharmaAwarded supplier
- Focus PharmaceuticalsAwarded supplier
- Fresenius KabiAwarded supplier
- Glaxo SmithklineAwarded supplier
- Intrapharm LabsAwarded supplier
- Kent PharmaceuticalsAwarded supplier
Show 16 more suppliers
- MartindaleAwarded supplier
- Merck Sharp & DohmeAwarded supplier
- Mercury PharmaceuticalsAwarded supplier
- MilpharmAwarded supplier
- Morningside PharmaceuticalsAwarded supplier
- MylanAwarded supplier
- Neon HealthcareAwarded supplier
- PfizerAwarded supplier
- RPH PharmaceuticalsAwarded supplier
- RanbaxyAwarded supplier
- SandozAwarded supplier
- Selective SuppliesAwarded supplier
- TevaAwarded supplier
- Torrent PharmaceuticalsAwarded supplier
- WockhardtAwarded supplier
- ZentivaAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.